Teradyne (TER) Financials

Teradyne’s latest quarter shows solid profitability and strong cash generation, but the balance sheet is tighter than it was a year ago and working capital consumed a lot of cash. In Q1 2026, revenue rose to $1.28 billion from $1.08 billion in Q4 2025 and $769 million in Q3 2025, while net income increased to $398.9 million. Operating cash flow was also strong at $265.1 million.

What stands out most is that the company is still producing healthy earnings, but cash has been pressured by large swings in operating assets and liabilities, especially receivables, inventory, and prepaid expenses. Teradyne also continued to return capital through dividends and buybacks while paying down debt and then issuing some new debt in the quarter.

• Revenue improved sequentially to $1.28 billion in Q1 2026, up from $1.08 billion in Q4 2025 and $769 million in Q3 2025.
• Net income climbed to $398.9 million, the strongest quarter in the set provided.
• Operating income rose to $473.0 million, showing excellent operating leverage on higher sales.
• Gross margin remained strong, with gross profit of $780.9 million on $1.28 billion of revenue.
• Operating cash flow was solid at $265.1 million in Q1 2026, supported by earnings and non-cash add-backs.
• The company still has a substantial liquidity cushion, including $241.9 million of cash and equivalents plus $3.7 million of short-term investments at quarter-end, along with $671.0 million in long-term investments.
• Teradyne’s share count has been relatively stable versus prior periods, and management continued repurchases, which can support per-share results.
• Q1 2026 free cash flow was pressured by $64.7 million of capex and $40.8 million of investment purchases.
• The company has been active on both sides of the capital structure, issuing $50 million of debt in Q1 2026 while repaying $250 million of debt, suggesting ongoing balance-sheet management.
• Goodwill and intangible assets remain sizable at about $563.2 million combined, so acquisition-related asset value is meaningful.
• Working capital was a major cash drag in Q1 2026, with changes in operating assets and liabilities using $203.2 million of cash.
• Cash and equivalents fell to $241.9 million from $553.4 million at year-end 2024 and $272.7 million in Q3 2025, showing a lower near-term cash buffer.
• Current liabilities increased to $1.01 billion, up from $995.0 million in Q3 2025, while current assets were $2.17 billion, leaving less balance-sheet flexibility than earlier periods.
• Restructuring charges have persisted across several quarters, including $3.4 million in Q1 2026, $15.1 million in Q4 2025, and $6.6 million in Q3 2025, suggesting ongoing cost actions.
• Revenue is still below the longer-standing highs seen in 2024, when quarterly sales were often in the $700 million to $800 million range, indicating the business remains somewhat cyclical.

Bottom line: Teradyne looks financially healthy in terms of earnings power and operating profitability, but investors should watch working-capital volatility and the decline in cash balances. The core business is still generating strong profits, yet the cash flow picture suggests the company is relying on careful balance-sheet management to keep capital returns and growth investments moving forward.